Analytical Data
-
基因名
TAGLN2
- Application
-
别名
TAGLN2；KIAA0120；Transgelin-2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P37802
-
表达区间
2-199aa
-
氨基酸序列
ANRGPAYGL SREVQQKIEK QYDADLEQIL IQWITTQCRK DVGRPQPGRE NFQNWLKDGT VLCELINALY PEGQAPVKKI QASTMAFKQM EQISQFLQAA ERYGINTTDI FQTVDLWEGK NMACVQRTLM NLGGLAVARD DGLFSGDPNW FPKKSKENPR NFSDNQLQEG KNVIGLQMGT NRGASQAGMT GYGMPRQIL
-
分子量
26kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAGLN2 (Transgelin-2) is a member of the calponin family of actin-binding proteins, primarily involved in the regulation of smooth muscle contraction and cellular signaling pathways. It plays a crucial role in cytoskeletal dynamics and cellular processes such as cell migration, proliferation, and differentiation. Recent studies have highlighted the significance of TAGLN2 in various physiological and pathological conditions, including cancer metastasis, cardiovascular diseases, and fibrotic disorders. The expression levels of TAGLN2 have been correlated with tumor progression and patient prognosis in certain cancers, making it a potential biomarker and therapeutic target. To better understand its biological functions and implications in disease, researchers have focused on the production and characterization of recombinant TAGLN2 protein. By generating this protein through recombinant DNA technology, scientists aim to elucidate its structural properties, interaction with other cellular components, and its regulatory mechanisms. This research also facilitates the development of targeted therapies aimed at modulating TAGLN2 activity in disease contexts. Overall, the study of TAGLN2 recombinant protein is vital for advancing our understanding of its functions in health and disease, and it holds promise for the development of innovative therapeutic strategies.
